Trials / Withdrawn
WithdrawnNCT04037072
Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures
GI-108: Randomized Controlled Double-Blinded Trial Assessing the Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Fox Chase Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates Mitomycin C as treatment for dysphagia in adult subjects with documented complex esophageal anastomotic strictures. Patients will be randomized in a double-blinded fashion to topical application of normal saline (NS) or Mitomycin C (MMC) at the time of time of index procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mitomycin C | Topical application of Mytomycin C (MMC) |
| OTHER | Control | Topical application of Normal Saline |
Timeline
- Start date
- 2020-04-03
- Primary completion
- 2022-03-15
- Completion
- 2022-12-15
- First posted
- 2019-07-30
- Last updated
- 2022-04-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04037072. Inclusion in this directory is not an endorsement.